$12M Fuels Development of Wearable That Guides Brainwaves to Induce Sleep
The platform uses neurotechnology to read individual brainwaves and guide them in real time by responding with tailored stimulation.
The platform uses neurotechnology to read individual brainwaves and guide them in real time by responding with tailored stimulation.
Nyxoah SA has partnered with ResMed Germany to increase OSA awareness and therapy penetration in the German market.
A $2m funding round will accelerate the company's product development and regulatory and precommercialization efforts as it prepares for a 2024 entry into the North American CPAP market.
The clinical and regulatory milestones bring Nyxoah closer to offering its Genio neurostimulator solution to OSA patients in the US, according to the company.
Read MoreBioscience Association Manitoba unveiled four winners, including Cerebra, to be honored at its Annual Awards Dinner on March 2. Here’s which award Cerebra is picking up.
Read MoreSommetrics is advancing activities aimed at obtaining US Food and Drug Administration (FDA) market clearance for its flagship product, aerSleep II, which is targeted for the treatment of obstructive sleep apnea in those unable to use CPAP therapy.
Read MoreAstronauts find it difficult to maintain a natural circadian rhythm and generally complain about their sleep. A new project will examine the differences between human sleep patterns on earth and in space using an ear EEG.
Read MoreGenio 2.1’s upgrades are entirely related to the external components of the Genio system, as the implantable stimulator remains unchanged.
Read MoreX-trodes raised $4.5 million in funding in October 2021, and is now pursuing approval for the technology from the US Food and Drug Administration. If that goes well, the company hopes to start selling the device to sleep clinics in 2023.
Read More‘The results from the nocturnal adverse event questionnaire illustrate the burden that the second dose places on some patients.’
Read MoreThe first part of Onera’s post-market study will assess the diagnostic accuracy of Onera STS I in comparison with in-lab polysomnography.
Read MoreSunrise is developing a solution to analyze sleep using a 3-gram sensor coupled with artificial intelligence.
Read MoreSleep Number’s latest upgrades to its 360 smart beds include built-in sensors and mobility accessories to create more accessible smart beds so that people can age in place more comfortably or recover from injuries.
Read MoreMedical device technology company AppYea announced the acquisition of SleepX, a company focused on the development of a wearable sleep apnea monitor.
Read MoreKokoon’s Nightbuds use a PPG sensor to collect heart rate variability and motion data within a companion app.
Read MoreThe trial will evaluate the treatment benefits and safety of applying mild external vacuum over the upper airway with the aerSleep II device in subjects with moderate and severe OSA who are unable to use standard therapy with CPAP.
Read MoreSleepX’s DreamIT is a wristband will include several sensors and a vibration motor that will operate with an intensity adapted to the user’s reactions to accustom the user to sleep in the correct position using biofeedback.
Read MoreThe FDA will provide the Genio system with priority review and interaction with FDA’s experts throughout the premarket review phase until the product is commercialized in the United States.
Read More